Document is current
Any future updates will be listed below
-
Authors
Chen, Robert
Duffy, Áine
Mort, Matthew
Cooper, David N.
Rocheleau, Ghislain
Jordan, Daniel M.
Do, Ron
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32-GM007280)
National Institutes of Health (R01-HG013511)
National Institutes of Health (R35-GM124836)
- License Information
-
More Information
Article History
Received: 28 January 2025
Accepted: 19 May 2026
First Online: 11 June 2026
Declarations
:
: We accessed UK Biobank data under application ID 16218. The Institutional Review Board at the Icahn School of Medicine at Mount Sinai approved Mount Sinai Data Warehouse (MSDW) access (GCO no. 07–0529; STUDY-11–01139). This study complied with the Declaration of Helsinki.
: Not applicable.
: RD reports being a scientific cofounder, consultant and equity holder for Pensieve Health (pending) and being a consultant for Variant Bio, Character Bio and Cytokinetics. DNC and MM acknowledge receipt of funding from Qiagen Ltd through a License agreement with Cardiff University, which is relevant to the use of HGMD Professional in this work. AD is a current full-time employee of GSK. All other authors have no competing interests to declare.
